mulTiplex Immunoassay qualiTy assuRance Panel
ConditionGroup B Strep Infection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorSt George's, University of London
About this trial
Collection of serum from women not living with HIV, who received the GBS6 vaccine in the "a placebo-controlled clinical trial investigating the safety and immunogenicity of GBS6 in pregnant women with and without human immunodeficiency virus (HIV) infection and their infants" (GBS6) Clinical Trial in Kampala, Uganda, for the Development of Group B Streptococcus quality assurance panel for the GASTON multiplex anti-CPS IgG immunoassay
Eligibility criteria
Qualifiers
HIV-uninfected women who received the GBS6 vaccine during pregnancy and completed the whole period of study participation.
Reachable by phone
Willing and able to provide consent.
Willingness to provide a blood sample.
Disqualifiers
Receipt of blood/plasma transfusion in the last 3 months
Participants who receive treatment with immunosuppressive therapy, including cytotoxic agents or systemic corticosteroids.
Women who will test positive for Syphilis or HIV at screening
Current alcohol abuse or illicit drug use, or with a psychiatric condition
Trial design
Treatments tested in this trial
- Collection of 50mls of blood
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov